Associate Professor Malins is an ARC DECRA Fellow and leader in the development of cutting-edge synthetic technologies for the late-stage modification of peptides and proteins. She has co-authored several high-impact collaborative studies with multinational pharmaceutical companies (e.g. Bristol-Myers Squibb and Pfizer) and has commercialised new reagents for peptide synthesis and drug discovery. As an ECR, she has an impressive output relative to opportunity (h-index = 20; >1250 citations) and will drive next- generation peptide and protein science as co-leader of the Develop theme.